A study in subjects with impaired glucose tolerance (IGT) to evaluate effects of AO-128 on prevention of type 2 diabetes mellitus (Phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group comparison)
Not Applicable
- Conditions
- Impaired glucose tolerance (IGT)
- Registration Number
- JPRN-UMIN000001109
- Lead Sponsor
- Takeda Pharmaceutical Company Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1782
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patient has a history of diabetes mellitus 2. Patient with serious hepatic or renal disorders
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Progression from IGT to type 2 diabetes mellitus
- Secondary Outcome Measures
Name Time Method